These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 525889)

  • 1. Development and preliminary testing of an inactivated equine adenovirus vaccine.
    Lew AM; Smith HV; Studdert MJ
    Am J Vet Res; 1979 Dec; 40(12):1707-12. PubMed ID: 525889
    [No Abstract]   [Full Text] [Related]  

  • 2. Production and antigenic effect of experimental sheep adenovirus vaccines.
    Pálfi V; Belák S
    Acta Microbiol Acad Sci Hung; 1980; 27(2):135-9. PubMed ID: 7415875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro blastogenesis of equine lymphocytes by inactivated equine adenovirus type 1 antigen.
    Campbell TM; Studdert MJ
    Am J Vet Res; 1982 Nov; 43(11):1922-5. PubMed ID: 7181191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary note on use of an inactivated vaccine against equine plague].
    Bourdin P; Monnier-Cambon J
    Bull Acad Vet Fr; 1967 Apr; 40(4):187-91. PubMed ID: 4309539
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses.
    Barber TL; Walton TE; Lewis KJ
    Am J Vet Res; 1978 Apr; 39(4):621-5. PubMed ID: 646197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venezuelan equine encephalomyelitis: antibody response in vaccinated horses and resistance to infection with virulent virus.
    Jochim MM; Barber TL; Luedke AJ
    J Am Vet Med Assoc; 1973 Feb; 162(4):280-3. PubMed ID: 4686185
    [No Abstract]   [Full Text] [Related]  

  • 7. Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness.
    MacLachlan NJ; Balasuriya UB; Davis NL; Collier M; Johnston RE; Ferraro GL; Guthrie AJ
    Vaccine; 2007 Jul; 25(30):5577-82. PubMed ID: 17267078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies of an attenuated virus cell culture venezuelan equine encephalomyelitis vaccine.
    Sampson GR; Elliston NG; Miyat JA; Grueter HP; Gillespie JR; Rathmacher RP
    Mod Vet Pract; 1973 Aug; 54(8):19, 21-2. PubMed ID: 4803525
    [No Abstract]   [Full Text] [Related]  

  • 9. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
    Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of antibody against adenovirus in horses imported into Japan.
    Harasawa R; Konishi S; Ogata M
    Nihon Juigaku Zasshi; 1977 Aug; 39(4):451-4. PubMed ID: 199777
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccination against equine influenza: quid novi?
    Paillot R; Hannant D; Kydd JH; Daly JM
    Vaccine; 2006 May; 24(19):4047-61. PubMed ID: 16545507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter: Experimental infection of a horse with an equine adenovirus.
    Pascoe RR; Harden TJ; Spradbrow PB
    Aust Vet J; 1974 Jun; 50(6):278-9. PubMed ID: 4370149
    [No Abstract]   [Full Text] [Related]  

  • 13. Transmissibility of an attenuated Venezuelan equine encephalomyelitis vaccine virus.
    Taylor WM; Buff E
    J Am Vet Med Assoc; 1972 Jul; 161(2):159-63. PubMed ID: 4402529
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemagglutination-inhibiting antibodies to equine influenza viruses in Japanese horses and antigenic variation of the viruses.
    Kudo H; Ohde H; Yamanaka T; Ohtsuka Y; Matumoto M
    Kitasato Arch Exp Med; 1986 Sep; 59(3):49-55. PubMed ID: 2435948
    [No Abstract]   [Full Text] [Related]  

  • 15. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine.
    Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM
    Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and duration of immunity of a combined equine influenza and equine herpesvirus vaccine against challenge with an American-like equine influenza virus (A/equi-2/Kentucky/95).
    Heldens JG; Pouwels HG; van Loon AA
    Vet J; 2004 Mar; 167(2):150-7. PubMed ID: 14975389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of an attenuated strain of canine adenovirus (type 2) to raccoons, foxes, skunk, and mongoose.
    Sumner JW; Shaddock JH; Wu GJ; Baer GM
    Am J Vet Res; 1988 Feb; 49(2):169-71. PubMed ID: 3348527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response of horses after simultaneous or sequential vaccination against eastern, western, and Venezuelan equine encephalomyelitis.
    Jochim MM; Barber TL
    J Am Vet Med Assoc; 1974 Oct; 165(7):621-5. PubMed ID: 4422323
    [No Abstract]   [Full Text] [Related]  

  • 20. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.